BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ermongkonchai T, Khor R, Muralidharan V, Tebbutt N, Lim K, Kutaiba N, Ng SP. Stereotactic radiotherapy and the potential role of magnetic resonance-guided adaptive techniques for pancreatic cancer. World J Gastroenterol 2022; 28(7): 745-754 [PMID: 35317275 DOI: 10.3748/wjg.v28.i7.745]
URL: https://www.wjgnet.com/1007-9327/full/v28/i7/745.htm
Number Citing Articles
1
Tony Young, Mark Lee, Meredith Johnston, Theresa Nguyen, Rebecca Ko, Sankar Arumugam. Assessment of interfraction dose variation in pancreas SBRT using daily simulation MR imagesPhysical and Engineering Sciences in Medicine 2023; 46(4): 1619 doi: 10.1007/s13246-023-01324-6
2
D. Doppenberg, M. G. Besselink, C. H. J. van Eijck, M. P. W. Intven, B. Groot Koerkamp, G. Kazemier, H. W. M. van Laarhoven, M. Meijerink, I. Q. Molenaar, J. J. M. E. Nuyttens, R. van Os, H. C. van Santvoort, G. van Tienhoven, H. M. Verkooijen, E. Versteijne, J. W. Wilmink, F. J. Lagerwaard, A. M. E. Bruynzeel. Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs designBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10419-4
3
Hilario Yankey, Karen J. Ruth, Efrat Dotan, Sanjay Reddy, Joshua E. Meyer. Survival and Toxicity in Patients With Unresectable or Inoperable Biliary Tract Cancers With Ablative Radiation Therapy Versus Nonablative ChemoradiationAdvances in Radiation Oncology 2024; 9(4): 101412 doi: 10.1016/j.adro.2023.101412
4
Giulia Pacella, Maria Chiara Brunese, Eleonora D’Imperio, Marco Rotondo, Andrea Scacchi, Mattia Carbone, Germano Guerra. Pancreatic Ductal Adenocarcinoma: Update of CT-Based Radiomics Applications in the Pre-Surgical Prediction of the Risk of Post-Operative Fistula, Resectability Status and PrognosisJournal of Clinical Medicine 2023; 12(23): 7380 doi: 10.3390/jcm12237380
5
Xiaotao Dong, Kunlun Wang, Hui Yang, Ruilan Cheng, Yan Li, Yanqi Hou, Jiali Chang, Ling Yuan. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohortFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1266318
6
Petr Burkoň, Jan Trna, Marek Slávik, Radim Němeček, Tomáš Kazda, Petr Pospíšil, Milan Dastych, Michal Eid, Ivo Novotný, Tomáš Procházka, Miroslav Vrzal. Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer—A Critical Review and Practical ConsiderationBiomedicines 2022; 10(10): 2480 doi: 10.3390/biomedicines10102480
7
Karl Bordeau, Morgan Michalet, Aïcha Keskes, Simon Valdenaire, Pierre Debuire, Marie Cantaloube, Morgane Cabaillé, Fabienne Portales, Roxana Draghici, Marc Ychou, Eric Assenat, Thibault Mazard, Emmanuelle Samalin, Ludovic Gauthier, Pierre-Emmanuel Colombo, Sebastien Carrere, François-Régis Souche, Norbert Aillères, Pascal Fenoglietto, David Azria, Olivier Riou. Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry StudyCancers 2022; 15(1): 7 doi: 10.3390/cancers15010007
8
Jun Yeong Song, Eui Kyu Chie, Seong-Hee Kang, Yeon-Jun Jeon, Yoon-Ah Ko, Dong-Yun Kim, Hyun-Cheol Kang. Dosimetric evaluation of magnetic resonance imaging-guided adaptive radiation therapy in pancreatic cancer by extent of re-contouring of organs-at-riskRadiation Oncology Journal 2022; 40(4): 242 doi: 10.3857/roj.2022.00332
9
Hrvoje Kaučić, Domagoj Kosmina, Dragan Schwarz, Andreas Mack, Hrvoje Šobat, Adlan Čehobašić, Vanda Leipold, Iva Andrašek, Asmir Avdičević, Mihaela Mlinarić. Stereotactic Ablative Radiotherapy Using CALYPSO® Extracranial Tracking for Intrafractional Tumor Motion Management—A New Potential Local Treatment for Unresectable Locally Advanced Pancreatic Cancer? Results from a Retrospective StudyCancers 2022; 14(11): 2688 doi: 10.3390/cancers14112688
10
Florentine E F Timmer, Bart Geboers, Alette H Ruarus, Laurien G P H Vroomen, Evelien A C Schouten, Susan van der Lei, Danielle J W Vos, Madelon Dijkstra, Hannah H Schulz, Joyce Bakker, Bente A T van den Bemd, Petrousjka M van den Tol, Robbert S Puijk, Birgit I Lissenberg-Witte, Tanja D de Gruijl, Jan J J de Vries, Frank J Lagerwaard, Hester J Scheffer, Anna M E Bruynzeel, Martijn R Meijerink. MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trialThe Lancet Gastroenterology & Hepatology 2024; 9(5): 448 doi: 10.1016/S2468-1253(24)00017-7